Ipratropium Bromide
CAS No. 22254-24-6
Ipratropium Bromide ( Ipratropium Bromide )
Catalog No. M13553 CAS No. 22254-24-6
Ipratropium Bromide is an antagonist of M3 type muscarinic acetylcholine receptors, used for the treatment of chronic obstructive pulmonary disease (COPD).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 34 | In Stock |
|
100MG | 43 | In Stock |
|
200MG | 74 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIpratropium Bromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIpratropium Bromide is an antagonist of M3 type muscarinic acetylcholine receptors, used for the treatment of chronic obstructive pulmonary disease (COPD).
-
DescriptionIpratropium Bromide is an antagonist of M3 type muscarinic acetylcholine receptors, used for the treatment of chronic obstructive pulmonary disease (COPD).
-
SynonymsIpratropium Bromide
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorM3 mAChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number22254-24-6
-
Formula Weight412.37
-
Molecular FormulaC20H30BrNO3
-
Purity>98%(HPLC)
-
SolubilityDMSO:83 mg/mL (201.27 mM); Ethanol:83 mg/mL (201.27 mM); Water:83 mg/mL (201.27 mM)
-
SMILESCC([N+]1(C)C2CC(OC(C(C3=CC=CC=C3)CO)=O)CC1CC2)C.[Br-]
-
Chemical Name(endo,syn)-(±)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang W, et al. Eur J Pharmacol,010, 647(1-3), 178-187.
molnova catalog
related products
-
Cyclopentolate Hydro...
Cyclopentolate Hydrochloride is a muscarinic acetylcholine receptors antagonist with Kis of 1.62 27.5 and 2.63 nM for M1 M2 and M3 receptors respectively.
-
CCMI
CCMI is a potent and selective modulator of α7 nAChR-positive allosteric.
-
Thymidine
Thymidine overload due to Thymidine phosphorylase deficiency, and mitochondrial toxicity caused by antiviral Thymidine analogues.